Real-time enrollment status for this recurrent mantle cell lymphoma clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 7:49 PM UTC
| NCT Number | NCT04484012 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Mantle Cell Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 36 participants |
| Active Locations | 1 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | November 26, 2025 (Nov 26, 2025) |
As of August 28, 2026: Clinical trial NCT04484012 is currently recruiting participants. This phase2 study for recurrent mantle cell lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04484012 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04484012 was last updated Nov 26, 2025 (November 26, 2025). HelloStudys verifies this status automatically.